Related Experiment Videos

Update on mitochondrial toxicity of antiretrovirals and its link to lipodystrophy

Grace McComsey1

  • 1Rainbow Babies and Children's Hospital, Case Western Reserve University Center for AIDS Research, Cleveland, Ohio, USA. mccomsey.grace@clevelandactu.org

AIDS Reviews
|November 6, 2002
PubMed

Insights

Nucleoside analogs, vital for HIV treatment, can cause mitochondrial damage, leading to side effects like lipoatrophy and hyperlactatemia. This review explores these toxicities and their impact on body shape.

Area of Science:

  • HIV/AIDS treatment
  • Mitochondrial toxicology
  • Pharmacology

Background:

  • Antiretroviral drugs have improved HIV prognosis.
  • Nucleoside analogs are key HIV therapies.
  • Long-term use of these drugs causes toxicities.

Purpose of the Study:

  • Review the pathogenesis of mitochondrial damage from nucleoside analogs.
  • Discuss clinical consequences of this damage.
  • Focus on body-shape changes.

Main Methods:

  • Literature review of nucleoside analog toxicity.
  • Analysis of mitochondrial damage mechanisms.
  • Correlation of mitochondrial dysfunction with clinical outcomes.

Main Results:

  • Nucleoside analogs induce mitochondrial damage.
  • This damage manifests as lipoatrophy and hyperlactatemia.
  • Organ/tissue specific side effects occur.

Conclusions:

  • Mitochondrial damage is a significant concern with nucleoside analog therapy.
  • Understanding pathogenesis is crucial for managing side effects.
  • Body-shape changes are a notable clinical consequence.

Related Concept Videos